Cargando…
Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547977/ https://www.ncbi.nlm.nih.gov/pubmed/32915410 http://dx.doi.org/10.1007/s12325-020-01488-7 |
| _version_ | 1783592530863980544 |
|---|---|
| author | Rezk, Mourad F. Pieper, Burkhard |
| author_facet | Rezk, Mourad F. Pieper, Burkhard |
| author_sort | Rezk, Mourad F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7547977 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75479772020-10-19 Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review Rezk, Mourad F. Pieper, Burkhard Adv Ther Correction Springer Healthcare 2020-09-11 2020 /pmc/articles/PMC7547977/ /pubmed/32915410 http://dx.doi.org/10.1007/s12325-020-01488-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Correction Rezk, Mourad F. Pieper, Burkhard Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review |
| title | Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review |
| title_full | Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review |
| title_fullStr | Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review |
| title_full_unstemmed | Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review |
| title_short | Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review |
| title_sort | correction to: unlocking the value of anti-tnf biosimilars: reducing disease burden and improving outcomes in chronic immune-mediated inflammatory diseases: a narrative review |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547977/ https://www.ncbi.nlm.nih.gov/pubmed/32915410 http://dx.doi.org/10.1007/s12325-020-01488-7 |
| work_keys_str_mv | AT rezkmouradf correctiontounlockingthevalueofantitnfbiosimilarsreducingdiseaseburdenandimprovingoutcomesinchronicimmunemediatedinflammatorydiseasesanarrativereview AT pieperburkhard correctiontounlockingthevalueofantitnfbiosimilarsreducingdiseaseburdenandimprovingoutcomesinchronicimmunemediatedinflammatorydiseasesanarrativereview |